| Literature DB >> 35883183 |
Paweł Konieczka1,2, Bartłomiej Tykałowski3, Katarzyna Ognik4, Misza Kinsner5, Dominika Szkopek5, Maciej Wójcik5, Dariusz Mikulski6, Jan Jankowski6.
Abstract
Arginine (Arg), lysine (Lys), and methionine (Met) can be used to support the health status of turkeys. The present study investigated selected performance, gut integrity, and immunological parameters in turkeys reared in optimal or challenge conditions. The experiment lasted for 28 days, and it had a completely randomized 2 × 3 factorial design with two levels of dietary Arg, Lys and Met (high or low) and challenge with Clostridium perfringens (C. perfringens), Escherichia coli lipopolysaccharide (LPS) or no challenge (placebo). Increased dietary levels of Arg, Lys and Met had a beneficial effect on turkey performance and immunological parameters, and it improved selected indicators responsible for maintaining gut integrity in different challenge conditions. Under optimal conditions (with no challenge), high ArgLysMet diets did not compromise bird performance and they improved selected performance parameters in challenged birds. The immune system of turkeys was not excessively stimulated by high ArgLysMet diets, which did not disrupt the redox balance and had no negative effect on gut integrity. High ArgLysMet diets increased the expression levels of selected genes encoding nutrient transporters and tight junction proteins. However, the influence exerted by different dietary inclusion levels of Arg, Lys and Met on gut integrity was largely determined by the stressor (C. perfringens vs. LPS). Further studies are required to investigate the role of Arg, Lys and Met levels in the diet on the immune response, gut function and performance of turkeys in different challenge conditions.Entities:
Keywords: Turkey; essential amino acids; gut health; immune response; redox balance
Mesh:
Substances:
Year: 2022 PMID: 35883183 PMCID: PMC9327309 DOI: 10.1186/s13567-022-01080-7
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.829
Body weight (BW) and feed intake (Fint) of turkeys calculated for pre-, during-, and post-challenge periods
| Parameter | N | BW day 0, g | BW day 25, kg | BW day 28, kg | Fint days 0–25, kg | Fint days 25–28, kg | Fint days 0–28, kg | |
|---|---|---|---|---|---|---|---|---|
| Diet1 | ||||||||
| Low ArgLysMet | 24 | 60.11 | 1.148b | 1.337b | 1.708 | 0.379 | 2.087 | |
| High ArgLysMet | 24 | 60.1 | 1.207a | 1.388a | 1.757 | 0.423 | 2.18 | |
| Challenge2 | ||||||||
| No | 16 | 60.33 | 1.165 | 1.383 | 1.742 | 0.408 | 2.149 | |
| 16 | 59.83 | 1.178 | 1.349 | 1.702 | 0.391 | 2.093 | ||
| LPS | 16 | 60.15 | 1.19 | 1.354 | 1.755 | 0.404 | 2.159 | |
| Treatments | ||||||||
| Low ArgLysMet | No | 8 | 60.42 | 1.154 | 1.355 | 1.71 | 0.372 | 2.082 |
| Low ArgLysMet | 8 | 60 | 1.138 | 1.332 | 1.691 | 0.38 | 2.071 | |
| Low ArgLysMet | LPS | 8 | 59.91 | 1.153 | 1.322 | 1.724 | 0.386 | 2.11 |
| High ArgLysMet | No | 8 | 60.23 | 1.175 | 1.411 | 1.773 | 0.444 | 2.217 |
| High ArgLysMet | 8 | 59.67 | 1.218 | 1.365 | 1.713 | 0.403 | 2.115 | |
| High ArgLysMet | LPS | 8 | 60.39 | 1.228 | 1.386 | 1.786 | 0.422 | 2.208 |
| SEM | 0.112 | 0.01 | 0.011 | 0.018 | 0.011 | 0.026 | ||
| P-value | ||||||||
| Diet | 0.956 | 0.002 | 0.024 | 0.197 | 0.065 | 0.081 | ||
| Challenge | 0.202 | 0.52 | 0.387 | 0.493 | 0.829 | 0.54 | ||
| Diet × Challenge | 0.293 | 0.341 | 0.829 | 0.878 | 0.661 | 0.772 |
1Low ArgLysMet, diets with low arginine, lysine and methionine levels; High ArgLysMet, diets with high arginine, lysine and methionine levels.
2At 25, 26, and 27 days of age, birds were challenged either with C. perfringens type A strain 56 (C. perfringens) or lipopolysaccharide from Escherichia coli (LPS), or served as a placebo group with no challenge (No). a,bMeans within a row with different superscripts differ significantly (P < 0.05).
Body weight gain (BWG) and feed conversion ratio (FCR) of turkeys calculated for pre-, during-, and post-challenge periods
| Parameter | N | BWG days 0–25, kg | BWG days 25–28, kg | BWG days 0–28, kg | FCR days 0–25, kg/kg | FCR days 25–28, kg/kg | FCR days 25–28, kg/kg | |
|---|---|---|---|---|---|---|---|---|
| Diet1 | ||||||||
| Low ArgLysMet | 24 | 1.090b | 0.205 | 1.639b | 1.573 | 2.004 | 1.577 | |
| High ArgLysMet | 24 | 1.150a | 0.207 | 1.732a | 1.53 | 2.242 | 1.567 | |
| Challenge2 | ||||||||
| No | 16 | 1.106 | 0.23 | 1.711 | 1.58 | 2 | 1.578 | |
| 16 | 1.118 | 0.213 | 1.662 | 1.527 | 2.039 | 1.518 | ||
| LPS | 16 | 1.136 | 0.176 | 1.684 | 1.548 | 2.33 | 1.62 | |
| Treatments | ||||||||
| Low ArgLysMet | No | 8 | 1.094 | 0.213 | 1.648 | 1.571 | 1.988 | 1.563 |
| Low ArgLysMet | 8 | 1.078 | 0.22 | 1.634 | 1.575 | 1.864 | 1.559 | |
| Low ArgLysMet | LPS | 8 | 1.099 | 0.182 | 1.636 | 1.574 | 2.16 | 1.608 |
| High ArgLysMet | No | 8 | 1.118 | 0.248 | 1.774 | 1.59 | 2.012 | 1.593 |
| High ArgLysMet | 8 | 1.159 | 0.206 | 1.691 | 1.479 | 2.214 | 1.477 | |
| High ArgLysMet | LPS | 8 | 1.173 | 0.169 | 1.731 | 1.522 | 2.5 | 1.631 |
| SEM | 0.01 | 0.011 | 0.015 | 0.02 | 0.095 | 0.023 | ||
| Diet | 0.003 | 0.91 | 0.002 | 0.28 | 0.217 | 0.838 | ||
| Challenge | 0.442 | 0.11 | 0.382 | 0.542 | 0.311 | 0.21 | ||
| Diet × Challenge | 0.416 | 0.562 | 0.612 | 0.496 | 0.731 | 0.542 |
1 Low ArgLysMet, diets with low arginine, lysine and methionine levels; High ArgLysMet, diets with high arginine, lysine and methionine levels.
2 At 25, 26, and 27 days of age, birds were challenged either with C. perfringens type A strain 56 (C. perfringens) or lipopolysaccharide from Escherichia coli (LPS), or served as a placebo group with no challenge (No). a,bMeans within a row with different superscripts differ significantly (P < 0.05).
Figure 1Serum FITC-d concentrations in turkeys fed high or low dietary arginine, lysine and methionine levels (A) and as a result of either infection, LPS challenge or no challenge (B). a,bMeans within a row with different superscripts differ significantly (P < 0.05).
Selected immunological and redox parameters in the blood plasma of turkeys at 28 days of age
| Parameter | N | Ig A [ng/mL] | Ig M [ng/mL] | Ig Y [ng/mL] | IL-6 [pg/mL] | IL-2 [pg/mL] | Cp [ng/mL] | Casp3 [ng/mL] | Casp8 [ng/mL] | OGG1 [ng/mL] | APEX1 [ng/mL] | 8-OHdG [ng/mL] | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diet1 | |||||||||||||
| Low ArgLysMet | 24 | 2.457a | 2.759 | 2356.88 | 4.4 | 17.96 | 29.17 | 0.989 | 1.653 | 6.177 | 202.4 | 27.43a | |
| High ArgLysMet | 24 | 2.216b | 2.669 | 2343.92 | 5.158 | 16.88 | 29.85 | 1.067 | 1.691 | 5.758 | 185.8 | 22.99b | |
| Challenge | |||||||||||||
| No | 16 | 2.399a | 2.741a | 2407.58a | 5.244 | 17.29 | 23.41b | 1.022 | 1.469 | 5.811 | 192.5ab | 34.40a | |
| 16 | 2.457a | 2.882a | 2406.39a | 5.098 | 19.96 | 36.43a | 1.039 | 1.874 | 5.997 | 220.8a | 21.64b | ||
| LPS | 16 | 2.153b | 2.520b | 2237.23b | 3.994 | 15 | 28.69ab | 1.023 | 1.672 | 6.095 | 169.1b | 19.58b | |
| Treatments2 | |||||||||||||
| Low ArgLysMet | No | 8 | 2.403a | 2.891 | 2382.22 | 4.898 | 15.90ab | 23.94 | 1.012 | 1.32 | 6.138 | 217.6 | 37.49 |
| Low ArgLysMet | 8 | 2.595a | 2.722 | 2394.5 | 4.723 | 13.49ab | 33.69 | 0.936 | 1.846 | 6.492 | 226.3 | 25.54 | |
| Low ArgLysMet | LPS | 8 | 2.373a | 2.664 | 2293.92 | 3.58 | 24.48a | 29.86 | 1.02 | 1.792 | 5.903 | 163.4 | 19.24 |
| High ArgLysMet | No | 8 | 2.395a | 2.591 | 2432.95 | 5.591 | 18.69ab | 22.88 | 1.032 | 1.619 | 5.483 | 167.3 | 31.32 |
| High ArgLysMet | 8 | 2.319a | 3.042 | 2418.28 | 5.474 | 26.44a | 39.16 | 1.143 | 1.903 | 5.503 | 215.3 | 17.73 | |
| High ArgLysMet | LPS | 8 | 1.933b | 2.375 | 2180.53 | 4.408 | 5.51b | 27.51 | 1.027 | 1.551 | 6.288 | 174.7 | 19.93 |
| SEM | 0.041 | 0.041 | 21.686 | 0.252 | 1.688 | 1.665 | 0.029 | 0.078 | 0.195 | 8.572 | 1.469 | ||
| Diet | 0.001 | 0.115 | 0.728 | 0.13 | 0.707 | 0.824 | 0.181 | 0.803 | 0.294 | 0.31 | 0.049 | ||
| Challenge | 0.001 | 0.001 | 0.001 | 0.087 | 0.371 | 0.005 | 0.964 | 0.111 | 0.837 | 0.043 | 0.001 | ||
| Diet × Challenge | 0.025 | 0.001 | 0.164 | 0.994 | 0.001 | 0.541 | 0.295 | 0.365 | 0.343 | 0.304 | 0.253 |
1Low ArgLysMet, diets with low arginine, lysine and methionine levels; High ArgLysMet, diets with high arginine, lysine and methionine levels.
2At 25, 26, and 27 days of age, birds were challenged either with C. perfringens type A strain 56 (C. perfringens) or lipopolysaccharide from Escherichia coli (LPS), or served as a placebo group with no challenge (No). a,bMeans within a row with different superscripts differ significantly (P < 0.05).
Selected immunological and redox parameters in the jejunum of turkeys at 28 days of age
| Parameter | N | Amyloid A [ug/g] | Ig A [ng/g] | Ig M [ng/g] | Ig Y [ng/g] | IL-6 [pg/g] | IL-2 [pg/g] | Cp | Casp3 [ng/g] | Casp8 [ng/g] | OGG1 [ng/g] | APEX1 [ng/gL] | 8-OHdG [ng/mL] | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diet1 | ||||||||||||||
| Low ArgLysMet | 24 | 26.87 | 44.61 | 31.45 | 326.7 | 9.72 | 11.65 | 598.7 | 15.41 | 30.44 | 63.92b | 3.243 | 24.44 | |
| High ArgLysMet | 24 | 22.59 | 45.3 | 32.16 | 330.5 | 10.38 | 11.12 | 624.9 | 14.15 | 31.18 | 74.12a | 3.553 | 22.92 | |
| Challenge2 | ||||||||||||||
| No | 16 | 23.34 | 41.78b | 32.63 | 335.0a | 8.71b | 10.94 | 562.2b | 14.37 | 32.20a | 72.73a | 3.287 | 19.18c | |
| 16 | 25.76 | 56.84a | 33.59 | 385.2a | 11.94a | 12.30 | 624.0ab | 14.03 | 27.63b | 63.05b | 3.11 | 24.37b | ||
| LPS | 16 | 25.09 | 36.23b | 29.19 | 265.6b | 9.49ab | 10.92 | 649.2a | 15.94 | 32.60a | 71.28ab | 3.798 | 27.47a | |
| Treatments | ||||||||||||||
| Low ArgLysMet | No | 8 | 19.44 | 34.68 | 30.60ab | 318.7 | 7.08b | 8.92 | 521.7 | 15.47 | 34.28 | 73.36 | 3.506 | 21.64 |
| Low ArgLysMet | 8 | 23.25 | 52.31 | 29.82ab | 360.3 | 11.10ab | 10.77 | 617.4 | 14.93 | 24.88 | 63.96 | 2.894 | 23.82 | |
| Low ArgLysMet | LPS | 8 | 37.93 | 46.83 | 33.91ab | 301.2 | 10.98ab | 15.27 | 656.9 | 15.83 | 32.15 | 54.44 | 3.33 | 27.84 |
| High ArgLysMet | No | 8 | 27.24 | 48.89 | 34.65a | 351.4 | 10.35ab | 12.96 | 602.7 | 13.27 | 30.12 | 72.09 | 3.067 | 16.73 |
| High ArgLysMet | 8 | 28.26 | 61.38 | 37.35a | 410 | 12.78a | 13.83 | 630.5 | 13.13 | 30.37 | 62.14 | 3.327 | 24.92 | |
| High ArgLysMet | LPS | 8 | 12.25 | 25.63 | 24.48b | 230 | 7.99ab | 6.57 | 641.4 | 16.05 | 33.04 | 88.11 | 4.266 | 27.1 |
| SEM | ||||||||||||||
| 1.585 | 2.41 | 1.08 | 11.263 | 0.658 | 0.728 | 14.85 | 0.352 | 0.78 | 2.039 | 0.211 | 0.675 | |||
| Diet | 0.068 | 0.848 | 0.709 | 0.848 | 0.507 | 0.589 | 0.361 | 0.06 | 0.588 | 0.001 | 0.247 | 0.08 | ||
| Challenge | 0.001 | 0.001 | 0.151 | 0.001 | 0.027 | 0.423 | 0.046 | 0.049 | 0.008 | 0.015 | 0.100 | 0.001 | ||
| Diet × Challenge | 0.001 | 0.001 | 0.002 | 0.029 | 0.034 | 0.001 | 0.370 | 0.276 | 0.022 | 0.001 | 0.111 | 0.001 |
1Low ArgLysMet, diets with low arginine, lysine and methionine levels; High ArgLysMet, diets with high arginine, lysine and methionine levels.
2At 25, 26, and 27 days of age, birds were challenged either with C. perfringens type A strain 56 (C. perfringens) or lipopolysaccharide from Escherichia coli (LPS), or served as a placebo group with no challenge (No). a,bMeans within a row with different superscripts differ significantly (P < 0.05).
Figure 2Percentages of peripheral blood T (CD4, CD4CD8α, CD8α) and B (IgM) cell subpopulations in turkeys fed high or low dietary arginine, lysine and methionine levels (left side of the figure) and as a result of either infection, LPS challenge or no challenge (right side of the figure). a,bMeans within a row with different superscripts differ significantly (P < 0.05). A significant interaction (diet × challenge) was noted (P = 0.047) for CD4+ CD8α+.
Figure 3Percentages of splenic T (CD4, CD4CD8α, CD8α) and B (IgM) cell subpopulations in turkeys fed high or low dietary arginine, lysine and methionine levels (left side of the figure) and as a result of either infection, LPS challenge or no challenge (right side of the figure). a,b,cMeans within a row with different superscripts differ significantly (P < 0.05).
mRNA expression levels of selected genes encoding gut integrity regulators, nutrient transporters and digestive enzymes in turkeys at 28 days of age
| Parameter | N | GLUT 1 | GLUT 2 | PEPT 1 | PEPT 2 | ASCT 1 | ZO 1 | OCCL | BoAT | SI | EAAT 3 | CCK 1 | CAT 1 | CCK | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diet1 | |||||||||||||||
| Low ArgLysMet | 24 | 0.812 | 0.236 | 0.196a | 0.789b | 0.928 | 0.565 | 0.611 | 0.874 | 0.788a | 0.301 | 6.551 | 1.000 | 2.368 | |
| High ArgLysMet | 24 | 0.803 | 0.226 | 0.147b | 1.107a | 0.928 | 0.56 | 0.698 | 0.66 | 0.563b | 0.33 | 6.499 | 1.076 | 2.075 | |
| Challenge2 | |||||||||||||||
| No | 16 | 0.865 | 0.390a | 0.271a | 1.126 | 1.187a | 0.648 | 0.919a | 1.003 | 0.946a | 0.502a | 6.144 | 1.433a | 1.732 | |
| 16 | 0.736 | 0.155b | 0.135b | 0.757 | 0.728b | 0.494 | 0.424c | 0.686 | 0.573b | 0.183b | 5.654 | 0.988b | 2.569 | ||
| LPS | 16 | 0.821 | 0.148b | 0.109b | 0.962 | 0.868b | 0.545 | 0.620b | 0.612 | 0.508b | 0.262b | 7.777 | 0.692c | 2.363 | |
| Treatments | |||||||||||||||
| Low ArgLysMet | No | 8 | 0.699 | 0.380 | 0.313 | 0.939 | 1.035ab | 0.606 | 0.747 | 1.202 | 1.162 | 0.495 | 4.878 | 1.200 | 1.936 |
| Low ArgLysMet | 8 | 0.769 | 0.188 | 0.144 | 0.826 | 0.768b | 0.506 | 0.473 | 0.794 | 0.703 | 0.225 | 5.914 | 0.946 | 2.986 | |
| Low ArgLysMet | LPS | 8 | 0.968 | 0.138 | 0.132 | 0.601 | 0.980ab | 0.583 | 0.613 | 0.627 | 0.499 | 0.185 | 8.86 | 0.854 | 2.181 |
| High ArgLysMet | No | 8 | 1.03 | 0.399 | 0.229 | 1.312 | 1.340a | 0.691 | 1.091 | 0.804 | 0.73 | 0.51 | 7.41 | 1.666 | 1.529 |
| High ArgLysMet | 8 | 0.703 | 0.121 | 0.126 | 0.687 | 0.688b | 0.481 | 0.375 | 0.578 | 0.443 | 0.142 | 5.393 | 1.031 | 2.151 | |
| High ArgLysMet | LPS | 8 | 0.674 | 0.159 | 0.085 | 1.323 | 0.756b | 0.508 | 0.627 | 0.597 | 0.517 | 0.339 | 6.694 | 0.531 | 2.546 |
| SEM | 0.043 | 0.020 | 0.015 | 0.077 | 0.051 | 0.026 | 0.042 | 0.078 | 0.051 | 0.03 | 0.459 | 0.068 | 0.152 | ||
| Diet | 0.906 | 0.668 | 0.034 | 0.025 | 0.997 | 0.928 | 0.117 | 0.165 | 0.007 | 0.526 | 0.953 | 0.435 | 0.317 | ||
| Challenge | 0.421 | 0.001 | 0.001 | 0.101 | 0.001 | 0.053 | 0.001 | 0.095 | 0.001 | 0.001 | 0.131 | 0.001 | 0.058 | ||
| Diet × Challenge | 0.010 | 0.171 | 0.501 | 0.045 | 0.037 | 0.433 | 0.005 | 0.618 | 0.074 | 0.110 | 0.099 | 0.007 | 0.240 |
1Low ArgLysMet, diets with low arginine, lysine and methionine levels; High ArgLysMet, diets with high arginine, lysine and methionine levels.
2At 25, 26, and 27 days of age, birds were challenged either with C. perfringens type A strain 56 (C. perfringens) or lipopolysaccharide from Escherichia coli (LPS), or served as a placebo group with no challenge (No). a,b,cMeans within a row with different superscripts differ significantly (P < 0.05). GLUT 1: Glucose transporter-1, GLUT 2: Glucose transporter-2, PEPT 1: Peptide transporter-1, PEPT 2: Peptide transporter-2, ASCT 1: Alanine, serine, cysteine, and threonine transporter, ZO 1: Zonula occludens 1, OCCL: Occludin, BoAT: Solute carrier family 6, member 19, SI: Sucrase isomaltase, EAAT 3: Excitatory amino acid transporter 3, CCK 1: Cholecystokinin type 1 receptor, CAT 1: Cationic amino acid transporter-1, CCK: Cholecystokinin.